The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
Open accessAbstract
Glucocorticoid-induced osteoporosis may be due, in part, to increased apoptosis of osteocytes and osteoblasts, and bisphosphonates (BPs) are effective in the management of this condition. We have tested the hypothesis that BPs suppress apoptosis in these cell types. Etidronate, alendronate, pamidronate, olpadronate, or amino-olpadronate (IG9402, a bisphosphonate that lacks antiresorptive activity) at 10(-9) to 10(-6) M prevented apoptosis of murine osteocytic MLO-Y4 cells, whether it was induced by etoposide, TNF-alpha, or the synthetic glucocorticoid dexamethasone. BPs also inhibited apoptosis of primary murine osteoblastic cells isolated from calvaria. Similar antiapoptotic effects on MLO-Y4 and osteoblastic cells were seen with nanomolar concentrations of the peptide hormone calcitonin. The antiapoptotic effect of BPs and calcitonin was associated with a rapid increase in the phosphorylated fraction of extracellular signal regulated kinases (ERKs) and was blocked by specific inhibitors of ERK activation. Consistent with these in vitro results, alendronate abolished the increased prevalence of apoptosis in vertebral cancellous bone osteocytes and osteoblasts that follows prednisolone administration to mice. These results suggest that the therapeutic efficacy of BPs or calcitonin in diseases such as glucocorticoid-induced osteoporosis may be due, in part, to their ability to prevent osteocyte and osteoblast apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Induction of apoptosis in MLO/Y4 cells by etoposide, TNF-␣, or glucocorticoids was prevented by pretreatment of the cells with 5-10 ng/mL sCT.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [167]
The cited source says what the claim attributes to it.
In the citing paper
“The authors suggest that the therapeutic effect of calcitonin in diseases such as glucocorticoid-induced osteoporosis may be partly due to inhibition of osteocyte apoptosis (167).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [167]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thornberry, N. A., & Lazebnik, Y. A. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,857
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,273
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,374
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Dyk, D. E. V., Pitts, W. J., Earl, R. A., Hobbs, F. W., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18623 · Cited by 3,016
The Fire of Life: An Introduction to Animal Energetics
Kleiber, M. (1975) · Medical Entomology and Zoology · Cited by 2,529
A short amino acid sequence able to specify nuclear location
Kalderon, D., Roberts, B., Richardson, W. D., & Smith, A. E. (1984) · Cell · doi:10.1016/0092-8674(84)90457-4 · Cited by 2,511
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 12×
“The TUNEL reaction was performed according to the manufacturer’s instructions, using 0.15% CuSO4 for color enhancement.”
BackgroundMethodResultInfluentialSelf-citationLuckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068
Research works printed but not linked: 8
- Cummings, 1996, J Bone Miner Res, 11(Suppl.), S102
- Marotti, 1990, Ital J Miner Electrol Metab, 4, 93
- Dennison, 1999, Osteoporos Int, 9, S16
- Weinstein, 1998, Bone, 23(Suppl), S461
- Falcini, 1996, Calcif Tissue Int, 58, 166
- Grignani, 1998, Cancer Res, 58, 14
- Giuliani, 1995, J Bone Miner Res, 10(Suppl), S171
- Marotti, 1996, Ital J Anat Embryol, 101, 25
Cited by
Sorted by citations
Items 201–300 of 888
Autophagy as a target for glucocorticoid-induced osteoporosis therapy
Shen, G., Ren, H. J., Shang, Q., Qiu, T., Yu, X., Zhang, Z., Huang, J., Zhao, W., Zhang, Y., Liang, D., et al. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2776-1 · Cited by 76
Dobnig, H., Hofbauer, L. C., Viereck, V., Obermayer-Pietsch, B., & Fahrleitner-Pammer, A. (2006) · Osteoporosis International · doi:10.1007/s00198-005-0035-4 · Cited by 76
McCarthy, E. A., Raggio, C., Hossack, M., Miller, E. A., Jain, S., Boskey, A. L., & Camacho, N. P. (2002) · Pediatric Research · doi:10.1203/00006450-200211000-00010 · Cited by 76
The effect of zoledronate during bone healing
Matos, M. A., Tannuri, U., & Guarniero, R. (2010) · Journal of Orthopaedics and Traumatology · doi:10.1007/s10195-010-0083-1 · Cited by 76
Mechanical, hormonal and metabolic influences on blood vessels, blood flow and bone
Prisby, R. D. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0666 · Cited by 76
The skeleton as a unique environment for breast cancer cells
Mastro, A. M., Gay, C. V., & Welch, D. R. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022995403081 · Cited by 76
Gortázar, A. R., Martín-Millán, M., Bravo, B., Plotkin, L. I., & Bellido, T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437921 · Cited by 77
Self-citationInhibition of osteoblast apoptosis by thrombin
Pagel, C. N., de Niese, M. R., Abraham, L. A., Chinni, C., Song, S., Pike, R. N., & Mackie, E. J. (2003) · Bone · doi:10.1016/s8756-3282(03)00209-6 · Cited by 75
Alendronate Improves Screw Fixation in Osteoporotic Bone
Moroni, A., Faldini, C., Hoang‐Kim, A., Pegreffi, F., & Giannini, S. (2007) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-200701000-00014 · Cited by 73
Histomorphometric analysis of glucocorticoid-induced osteoporosis
Carbonare, L. D., Bertoldo, F., Valenti, M. T., Zenari, S., Zanatta, M., Sella, S., Giannini, S., & Cascio, V. L. (2005) · Micron · doi:10.1016/j.micron.2005.07.009 · Cited by 71
Martini, G., Gennari, L., Merlotti, D., Salvadori, S., Franci, M. B., Campagna, S., Avanzati, A., De Paola, V., Valleggi, F., & Nuti, R. (2007) · Bone · doi:10.1016/j.bone.2006.08.003 · Cited by 72
Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 77
Alternative bisphosphonate targets and mechanisms of action
Bukowski, J. F., Dascher, C. C., & Das, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.075 · Cited by 72
Feng, R., Li, F., Yuan, Z., Wang, D., Wang, F., Tan, B., Han, S., Li, T., Li, D., & Han, Y. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9533-8 · Cited by 71
Osteogenic activity of vanadyl(IV)–ascorbate complex: Evaluation of its mechanism of action
Cortizo, A. M., Molinuevo, M. S., Barrio, D. A., & Bruzzone, L. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.12.007 · Cited by 70
Alendronate Enhances Osteogenic Differentiation of Bone Marrow Stromal Cells: A Preliminary Study
Kim, H. K., Kim, J. H., Abbas, A. A., & Yoon, T. R. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0409-y · Cited by 70
The bisphosphonate pamidronate is a potent inhibitor of human osteosarcoma cell growth in vitro
Sonnemann, J., Eckervogt, V., Truckenbrod, B., Boos, J., Winkelmann, W., & van Valen, F. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200106000-00007 · Cited by 70
Connexin 43 hemichannels and intracellular signaling in bone cells
Plotkin, L. I. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00131 · Cited by 66
Self-citationValkealahti, M., Mönkkönen, H., Mönkkönen, J., Leskelä, H., Parikka, V., Hämäläinen, M. M. J., & Lehenkari, P. P. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto_176.x · Cited by 69
Alternative Indications for Bisphosphonate Therapy
Landesberg, R., Eisig, S. B., Fennoy, I., & Siris, E. S. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2008.12.006 · Cited by 69
Moriishi, T., Maruyama, Z., Fukuyama, R., Ito, M., Miyazaki, T., Kitaura, H., Ohnishi, H., Furuichi, T., Kawai, Y., Masuyama, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027487 · Cited by 68
Sensitivity of bone to glucocorticoids
Cooper, M. S. (2004) · Clinical Science · doi:10.1042/cs20040070 · Cited by 68
Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1
Tai, Y., Cho, S., & Anderson, K. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01822 · Cited by 68
Tauchmanovà, L., Ricci, P., Serio, B., Lombardi, G., Colao, A. A. L., Rotoli, B., & Selleri, C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0509 · Cited by 67
Liu, X., Wei, Y., Xuan, C., Liu, L., Chen, L., Chai, M., Zhang, Z., Wang, L., & Shi, X. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000076 · Cited by 66
Bivi, N., Lezcano, V., Romanello, M., Bellido, T., & Plotkin, L. I. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23208 · Cited by 68
Self-citationBone Healing in Children With Osteogenesis Imperfecta Treated With Bisphosphonates
Pizones, J., Plotkin, H., Parra-Garcia, J. I., Alvarez, P., Gutierrez, P., Bueno, A. I. M., & Fernandez-Arroyo, A. F. (2005) · Journal of Pediatric Orthopaedics · doi:10.1097/01.bpo.0000152940.10487.c9 · Cited by 66
Tauchmanovà, L., Colao, A. A. L., Lombardi, G., Rotoli, B., & Selleri, C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2870 · Cited by 67
Bone-bound bisphosphonate inhibits growth of adjacent non-bone cells
Cornish, J., Bava, U., Callon, K. E., Bai, J., Naot, D., & Reid, I. R. (2011) · Bone · doi:10.1016/j.bone.2011.07.020 · Cited by 66
Bivi, N., Nelson, M. T., Faillace, M. E., Li, J., Miller, L. M., & Plotkin, L. I. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9628-z · Cited by 65
Self-citationHigh Bone Mass in Mice Lacking Cx37 Because of Defective Osteoclast Differentiation
Pacheco‐Costa, R., Hassan, I., Reginato, R. D., Davis, H. M., Bruzzaniti, A., Allen, M. R., & Plotkin, L. I. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.529735 · Cited by 65
Self-citationErben, R. G., Mosekilde, L., Thomsen, J. S., Weber, K., Stähr, K., Leyshon, A., Smith, S. Y., & Phipps, R. J. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.8.1498 · Cited by 65
The effect of alendronate on resorption of the alveolar bone following tooth extraction
Altundal, H., & Güvener, Ö. (2004) · International Journal of Oral and Maxillofacial Surgery · doi:10.1006/ijom.2002.0472 · Cited by 65
Oxidation-specific epitopes restrain bone formation
Ambrogini, E., Que, X., Wang, S., Yamaguchi, F., Weinstein, R. S., Tsimikas, S., Manolagas, S. C., Witztum, J. L., & Jilka, R. L. (2018) · Nature Communications · doi:10.1038/s41467-018-04047-5 · Cited by 65
Self-citationCurrent Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis
Raterman, H. G., Bultink, I. E. M., & Lems, W. F. (2019) · Drugs · doi:10.1007/s40265-019-01145-6 · Cited by 64
Kim, K.-S., Choi, Y.-H., Kim, K.-H., Lee, Y., Kim, C., Moon, S.-H., Kang, S. G., & Park, Y. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.04.010 · Cited by 64
Kaji, H., Naito, J., Inoue, Y., Sowa, H., Sugimoto, T., & Chihara, K. (2008) · Hormone and Metabolic Research · doi:10.1055/s-0028-1082051 · Cited by 63
Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells
Gangoiti, M. V., Cortizo, A. M., Arnol, V., Felice, J. I., & McCarthy, A. D. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.031 · Cited by 63
Matsumoto, Y., Otsuka, F., Takano, M., Mukai, T., Yamanaka, R., Takeda, M., Miyoshi, T., Inagaki, K., Sada, K., & Makino, H. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.05.004 · Cited by 62
Tauchmanovà, L., SIMONE, G. D., Musella, T., Orio, F., Ricci, P., Nappi, C., Lombardi, G., Colao, A. A. L., Rotoli, B., & Selleri, C. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705196 · Cited by 62
Pharmacological management of osteogenesis
Nardone, V., D’Asta, F., & Brandi, M. L. (2014) · Clinics · doi:10.6061/clinics/2014(06)12 · Cited by 62
Toscani, D., Palumbo, C., Palma, B. D., Ferretti, M., Bolzoni, M., Marchica, V., Sena, P., Martella, E. M., Mancini, C., Ferri, V., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2741 · Cited by 62
Kamijo, S., Nakajima, A., Ikeda, K., Aoki, K., Ohya, K., Akiba, H., Yagita∥, H., & Okumura, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.06.098 · Cited by 59
Aguirre, J. I., Castillo, E. J., & Kimmel, D. B. (2021) · Bone · doi:10.1016/j.bone.2021.116168 · Cited by 62
Medication-Related Osteonecrosis of the Jaw
Allen, M. R. (2015) · Oral and Maxillofacial Surgery Clinics of North America · doi:10.1016/j.coms.2015.06.002 · Cited by 61
Regulation of bim in glucocorticoid‐mediated osteoblast apoptosis
Espiña, B., Liang, M., Russell, R. G. G., & Hulley, P. A. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21335 · Cited by 59
Non-Nuclear–Initiated Actions of the Estrogen Receptor Protect Cortical Bone Mass
Bartell, S. M., Li, H., Kim, H., Kim, S. H., Katzenellenbogen, J. A., Katzenellenbogen, B. S., Chambliss, K. L., Shaul, P. W., Roberson, P. K., Weinstein, R. S., et al. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1368 · Cited by 58
Self-citationThe decrease of particle-induced osteolysis after a single dose of bisphosphonate
von Knoch, M., Wedemeyer, C., Pingsmann, A., von Knoch, F., Hilken, G., Sprecher, C. M., Henschke, F., Barden, B., & Löer, F. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.06.010 · Cited by 59
Pathogenesis of aortic stenosis: not just a matter of wear and tear.
Sverdlov, A. L., Ngo, D. T. M., Chapman, M., Ali, O. A., Chirkov, Y. Y., & Horowitz, J. D. (2011) · Europe PMC (PubMed Central) · Cited by 58
Mechanisms of palmitate-induced lipotoxicity in osteocytes
Saedi, A. A., Bermeo, S., Plotkin, L. I., Myers, D. E., & Duque, G. (2019) · Bone · doi:10.1016/j.bone.2019.06.016 · Cited by 54
Self-citationKim, Y. H., Kim, G.-S., & Baek, J. (2002) · Experimental & Molecular Medicine · doi:10.1038/emm.2002.21 · Cited by 58
Bisphosphonates antagonise bone growth factors' effects on human breast cancer cells survival
Fromigué, O., Kheddoumi, N., & Body, J. J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601009 · Cited by 58
Physiology of the aging bone and mechanisms of action of bisphosphonates
Dominguez, L. J., Di Bella, G., Belvedere, M., & Barbagallo, M. (2011) · Biogerontology · doi:10.1007/s10522-011-9344-5 · Cited by 66
Effect of local delivery of alendronate on bone formation in bioactive glass grafting in rats
Srisubut, S., Teerakapong, A., Vattraphodes, T., & Taweechaisupapong, S. (2007) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2007.04.022 · Cited by 57
Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
Carbonare, L. D., Zanatta, M., Gasparetto, A., & Valenti, M. T. (2010) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s6285 · Cited by 57
Offel, J. F. V., Schuerwegh, A. J., Bridts, C. H., Stevens, W. J., & Clerck, L. S. D. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.10.925 · Cited by 58
Editorial: Cell Number Versus Cell Vigor--What Really Matters to a Regenerating Skeleton?
Manolagas, S. C. (1999) · Endocrinology · doi:10.1210/endo.140.10.7129 · Cited by 59
Self-citationChapter 1 Trophic Factors in the Carotid Body
Porzionato, A., Macchi, V., Parenti, A. R., & De, R. (2008) · International review of cytology · doi:10.1016/s1937-6448(08)01001-0 · Cited by 54
Li, B., Chau, J. F. L., Wang, Y., & Leong, W. F. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23049 · Cited by 58
Effect of buffalo casein-derived novel bioactive peptides on osteoblast differentiation
Reddi, S., Shanmugam, V. P., Kemgang, T. S., Kapila, S., & Kapila, R. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1346-2 · Cited by 56
Statins: lower lipids and better bones?
Rogers, M. J. (2000) · Nature Medicine · doi:10.1038/71484 · Cited by 56
Dexamethasone-induced apoptosis of osteocytic and osteoblastic cells is mediated by TAK1 activation
Ding, H., Wang, T., Xu, D., Cha, B., Liu, J., & Li, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.161 · Cited by 55
Zhang, X., Carpenter, D., Bokui, N., Soo, C. B., Miao, S., Truong, T. V., Wu, B. M., Chen, I., Vastardis, H., Tanizawa, K., et al. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.12.2126 · Cited by 55
Inoue, R., Matsuki, N., Gao, J., Kanematsu, T., Abe, K., & Hirata, M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706373 · Cited by 55
Glucocorticoid-induced osteoporosis
Tamura, Y., Okinaga, H., & Takami, H. E. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.08.018 · Cited by 56
Fan, J., Ruan, J., Liu, W., Zhu, L., Zhu, X., Yi, H., Cui, S., Zhao, J., & Cui, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.12138 · Cited by 54
The role of osteocytes and bone microstructure in preventing osteoporotic fractures
Hazenberg, J. G., Taylor, D. M., & Lee, T. C. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0222-y · Cited by 54
Bisphosphonate Therapeutics in Bone Disease: The Hard and Soft Data on Osteoclast Inhibition
Drake, M. T., & Cremers, S. C. L. M. (2010) · Molecular Interventions · doi:10.1124/mi.10.3.5 · Cited by 61
Shifting Paradigms on the Role of Connexin43 in the Skeletal Response to Mechanical Load
Lloyd, S. A. J., Loiselle, A. E., Zhang, Y., & Donahue, H. J. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2165 · Cited by 52
Maycas, M., McAndrews, K., Sato, A. Y., Pellegrini, G., Brown, D. M., Allen, M. R., Plotkin, L. I., Gortázar, A. R., Esbrit, P., & Bellido, T. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3007 · Cited by 54
Self-citationBoonen, S., Haentjens, P., Vandenput, L., & Vanderschueren, D. (2003) · Journal of Internal Medicine · doi:10.1046/j.0954-6820.2003.01258.x · Cited by 54
Terpos, E., Viniou, N. A., de la Fuente, J., Meletis, J., Voskaridou, E., Karkantaris, C., Vaiopoulos, G., Palermos, J., Yataganas, X., Goldman, J. M., et al. (2003) · European Journal Of Haematology · doi:10.1034/j.1600-0609.2003.02823.x · Cited by 54
Bisphosphonates in orthopedic applications
Wilkinson, J. M., & Little, D. G. (2011) · Bone · doi:10.1016/j.bone.2011.01.009 · Cited by 53
Statins as modulators of bone formation
Edwards, C. J., & Spector, T. D. (2002) · Arthritis Research & Therapy · doi:10.1186/ar399 · Cited by 53
The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis
Szulc, P. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.01.022 · Cited by 56
Osteocyte biology: its implications for osteoporosis.
Bonewald, L. F. (2004) · PubMed · Cited by 52
Effect of Bisphosphonates on the Progression of Degenerative Aortic Stenosis
Innasimuthu, A. L., & Katz, W. E. (2010) · Echocardiography · doi:10.1111/j.1540-8175.2010.01256.x · Cited by 52
Connexins and pannexins in the skeleton: gap junctions, hemichannels and more
Plotkin, L. I., & Stains, J. P. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1963-6 · Cited by 51
Self-citationUse of Bisphosphonates to Improve the Durability of Total Joint Replacements
Shanbhag, A. S. (2006) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/00124635-200604000-00003 · Cited by 50
Hara, K., Suda, T., Suda, J., Eguchi, M., Ihle, J. N., Nagata, S., Miura, Y., & Saito, M. (1988) · PubMed · Cited by 51
Biochemical Markers of Bone Turnover in Osteoporosis
Szulc, P., Bauer, D. C., & Eastell, R. (2013) · Wiley eBooks · doi:10.1002/9781118453926.ch35 · Cited by 51
Bassani, P., Panseri, S., Ruffini, A., Montesi, M., Ghetti, M., Zanotti, C., Tampieri, A., & Tuissi, A. (2014) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-014-5253-x · Cited by 50
Manolagas, S. C. (2006) · BoneKEy-Osteovision · doi:10.1138/20060193 · Cited by 50
Self-citationAllen, M. R., Follet, H., Khurana, M., Sato, M., & Burr, D. B. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0031-5 · Cited by 50
Autocrine signals promote osteoblast survival in culture
Tumber, A., Meikle, M., & Hill, P. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670383 · Cited by 50
Glucocorticoid-Induced Bone Loss in Dermatologic Patients
Summey, B. T., & Yosipovitch, G. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.1.82 · Cited by 49
Brent, M. B. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108383 · Cited by 52
Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities
Shay, G., Hazlehurst, L., & Lynch, C. C. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1345-4 · Cited by 48
The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing
Allen, M. R. (2011) · Odontology · doi:10.1007/s10266-010-0153-0 · Cited by 49
Piscitelli, P., Iolascon, G., Innocenti, M., Civinini, R., Rubinacci, A., Muratore, M., D’Arienzo, M., Leali, P. T., Carossino, A. M., & Brandi, M. L. (2013) · Europe PMC (PubMed Central) · Cited by 49
Osteoblast as a target of anti-osteoporotic treatment
Corrado, A., Sanpaolo, E. R., Bello, S. D., & Cantatore, F. P. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1362312 · Cited by 51
Glucocorticoid Excess in Bone and Muscle
Sato, A. Y., Peacock, M., & Bellido, T. (2018) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-018-9242-3 · Cited by 50
Self-citationAssaf, A. T., Smeets, R., Riecke, B., Weise, E., Gröbe, A., Blessmann, M., Steiner, T., Wikner, J., Friedrich, R. E., Heiland, M., et al. (2013) · PubMed · Cited by 48
Promotion of bone formation by simvastatin in polyethylene particle-induced osteolysis
von Knoch, F., Wedemeyer, C., Heckelei, A., Saxler, G., Hilken, G., Brankamp, J., Sterner, T., Landgraeber, S., Henschke, F., Löer, F., et al. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.02.008 · Cited by 48
Preosteocytes/Osteocytes Have the Potential to Dedifferentiate Becoming a Source of Osteoblasts
Torreggiani, E., Matthews, B. G., Pejda, S., Matić, I., Horowitz, M. C., Grčević, D., & Kalajzić, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075204 · Cited by 48
Yoshii, T., Hafeman, A. E., Nyman, J. S., Esparza, J. M., Shinomiya, K., Spengler, D. M., Mundy, G. R., Gutierrez, G. E., & Guelcher, S. A. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0585 · Cited by 48
Silva, R. A. B., Sousa‐Pereira, A. P., Lucisano, M. P., Romualdo, P. C., Paula‐Silva, F. W. G., Consolaro, A. G., da Silva, L. A. B., & Nelson‐Filho, P. (2019) · International Endodontic Journal · doi:10.1111/iej.13206 · Cited by 49
Iacopo, C., Falchetti, A., Merlotti, D., Cristina, E.-V., & Gennari, L. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1772051 · Cited by 56
Alendronate increases bone mineral density in long-term renal transplant recipients
Koç, M., Tuğlular, S., Arikan, H., Ozener, C. I., & Akoğlu, E. Ü. (2002) · Transplantation Proceedings · doi:10.1016/s0041-1345(02)02872-5 · Cited by 48
Osteonecrosis of the jaws and bisphosphonates. Report of three cases.
Pastor-Zuazaga, D., Crelgo, J. G., Gorbea, R. M., Pérez, A. E., & Sebastián-López, C. (2006) · PubMed · Cited by 48
Metadata
- Authors
- Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T.
- Affiliations
- University of Arkansas for Medical Sciences (US)
- Central Arkansas Veterans Healthcare System (US)
- Corresponding author
- Bellido, Teresita
- Venue
- Journal of Clinical Investigation
- Published
- 1999-11-15
- Volume
- 104
- Issue
- 10
- Pages
- 1363-1374
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC409837
- OpenAlex
- W2170680219
- Cited by
- 890
- References
- 62
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 11 · 2023: 13 · 2022: 19 · 2021: 15 · 2020: 21 · 2019: 24 · 2018: 24 · 2017: 29 · 2016: 41 · 2015: 26 · 2014: 54 · 2013: 44 · 2012: 40
- FWCI
- 11.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ar043003-05)
- National Institute on Aging (P01AG/AMS13918, P01AG013918)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR43003, R01AR046191)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- bisphosphonates, calcitonin, osteocyte apoptosis, osteoblast apoptosis, glucocorticoid-induced osteoporosis, alendronate, etidronate, pamidronate, extracellular signal-regulated kinase, ERK1/2 phosphorylation, dexamethasone, TNF-α, etoposide, prednisolone, MLO-Y4 cells, trabecular bone
- MeSH terms
- Pamidronate, Animals, Calcitonin, Cell Line, Cells, Cultured, Dexamethasone, Diphosphonates, Etoposide, Osteoblasts, Osteocytes, Prednisolone, Skull, Etidronic Acid, Tumor Necrosis Factor-alpha, Apoptosis, Alendronate, In Situ Nick-End Labeling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
